MaxiVision & Aswini Netralayam announce Joint Venture to create
premier eye care chain in Guntur & Prakasam Districts

MaxiVision & Aswini Netralayam announce Joint Venture to create
premier eye care chain in Guntur & Prakasam Districts

Hyderabad 31st Oct 2021: Hyderabad Based MaxiVision Super Specialty eye hospitals &
Narasaraopet (Guntur District)based Aswini Netralayam, of Dr.AAV Ramalinga Reddy, a renowned ophthalmic surgeon, qualified from AIIMS Delhi, and have over 35 years of eye care practice in Narasaraopet District, have entered into a Joint Venture to create a super specialty eye care chain in various towns, in Coastal Andhra Pradesh, with state of the art technology in eye care affordable to all economic segments.

Aswini Netralayam, under the leadership of Dr.Ramalinga Reddy, is one of the largesteye care service providers in Narsaraopet, with Super Speciality technology, and specialists. Aswini Netralayam is one of the best eye hospitals to have NABH accreditation amongst eye care players in the region.

The new JV merged with Maxivision Super Specialty Eye Hospitals, will be known as MAXIVISION DR RAMALINGA REDDY EYE HOSPITALS, and will commence operations from December 2021.

This dynamic growth model of practice development in the joint venture will be the 2nd unique model of Maxivision Group, to expand in Joint Venture and Joint Brand, with renowned surgeons of every potential town. 2019 October Maxivision entered into a pilot model of Joint Venture with 25-year-old reputed eye care practice of Dr.Sarath Babu Chilukuri as Sharat Maxivision Eye
Hospitals and has spread across Telangana with 7 eye care centers as of 2021. JV model is to build and supplement the practices of locally established reputed doctors by enhancing and upgrading the technology, adding efficient and professional management and clinical expertise, improving patient care processes, and leveraging the Maxivision brand synergizing with a local brand. The hospital of Dr.Ramalinga Reddy, who was practicing for the last 35 years, will now
expand with joint venture brand MAXIVISION DR.AAV RAMALINGA REDDY, to Macherla, and
Guntur from December 2021, and to other potential towns of Prakasam Districts post-April 2022.

Speaking on the Occasion Dr.GSK Velu – Chairman, MaxiVision Super Speciality Eye hospitals group said, with these new Joint ventures MaxiVision has emerged as an undisputed leader in the eye care sector in both the Telugu states i.e Telangana & Andhra Pradesh, and aims high to be the second-largest eye care services provider in India by 2022. We are happy to forgean alliance with Aswini Netralayam Dr.AAV Ramalinga Reddy, a leading eye care practitioner, in the district of Guntur, and joined handsto this enterprise. We target MaxiVision to be the second-largest eye
care chain in India, with around 100 hospitals, with 600 crores top line, over 400 doctors, and
super specialists.

Welcoming the delegates, Mr.Sudheer, COO of Maxivision Group of Eye Hospitals, said,
Maxivision is now a network of 20 Super Specialty Eye Care Hospitals. The expansion plan for Maxivision will be greenfield, and also Joint ventures with reputed ethical eye care practitioners. Maxivision will continue its expansion plan to Tamilnadu, Kerala, Karnataka, Orissa in 2022, and redefine the competitive landscape. The Joint venture model with Dr.Sharat in Warangal has grown 3 times ever since its inception and both promoters have gained reputation and wealth with the growth-oriented business model. This is encouraging quite a few other reputed practitioners in various states to come forward and forge the model with Maxivision.

Elaborating more on the JV Dr.Kasu Prasad Reddy, Founder Mentor, Co-Chairman,
MaxiVision Super Speciality Eye hospitals group said the “ 25 years ago I came back from
England and found Maxivision Group. The merger of Maxivision to the professional company run by Dr.Velu, has given me a lot of space to focus on enhancing excellence in my practice, do various research and innovations in eye care, and the network also grew exponentially, which would not have happened under my individual management. The Joint Venture model of the company has
opened a barrage of possibilities to practice expansion to various doctors who own large hospitals but are not able to justify or balance both clinical practice and enterprise growth.

Ophthalmologists should focus on patient care, surgical excellence and research, and business
management, expansion, strategic management should be left to professionals. That is where this unique model of JV works. It gives wings to ambitions of good practices
Dr.AAV Ramalinga Reddy, a good friend of mine, and hails from my native place, Narsaraopet, is an exemplary surgeon, with a vision to grow. Together under the guidance and leadership of Dr.GSK Velu, and a team of professionals, this group will grow to the vision in a short time”

Speaking on the Occasion, Dr.AAV Ramalinga Reddy Managing Director, Aswini Netralayam
added “ I have been always carrying a vision in my mind to grow my practice to tier 2 and Tier 3 potential towns of Andhra Pradesh, from where a lot of patients travel to my hospital in
Narasaraopet. After the bifurcation of the state, and emerging new towns, and populations, the
need for eye care is growing ominously, in all pockets of these two states. Watching MaxiVision grow its own as an undisputed leader, in Telangana and AP, I decided to partner with them, forge energies and grow together with a network of super specialty eye care providers. I am convinced that Dr.GSK Velu, a dynamic health care entrepreneur, Dr.Kasu Prasad Reddy, who is a pioneer
in eye healthcare, we will be very successful in this journey.

Dr.Sharat Babu Chilukuri, who merged his practice to Maxivision to the JV Sharat Maxivision Eye Hospital, congratulated and welcomed the new partner. He said the JV formed in 2019, has grown to 4 Super Specialty Eyecare chain and 4 Primary care centers in North Telangana, and now planning to expand to 6 more districts with Secondary Care centers, and 20 Vision Centers in deep
rural pockets of Telangana

Leave a Reply

Your email address will not be published. Required fields are marked *